The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis -- Roberts et al. 204 (7): 1559 Data Supplement - JEM--Roberts et al. Supplemental Material Index -- The Journal of Experimental Medicine

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20061845
Roberts et al.
• Table S1 (PDF)